Clinical trial Recruiting at 1 site Interventional Ages 7 to 10

Obstacle Course Training vs Neuromotor Task Training for kids with Developmental Coordination Disorder

Official title: Comparison of Obstacle Course Training and Neuromotor Task Training on Motor Planning and Functional Mobility in Children With Developmental Coordination Disorder

Run by Riphah International University · NCT07575178 · Data updated 2026-11-12

This trial tests whether Obstacle Course Training or Neuromotor Task Training helps 7- to 10-year-olds with DCD improve motor planning and daily movement.

Quick facts

Study typeInterventional
Ages7 Years to 10 Years
SexAll
Enrollment28 (estimated)
SponsorRiphah International University
Academic / other
Locations2 sites (Lahore, Punjab Province and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2026
Main results expectedAugust 1, 2026
Study endsAugust 10, 2026
Registry record updatedAugust 12, 2026
Trial IDNCT07575178 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 7–10 years diagnosed with DCD who meet the study’s cognitive and motor criteria and can participate in two weekly sessions.

Probably not a fit

Children with DCD who cannot tolerate the training sessions or have conditions that interfere with participation may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized study compares two pediatric motor interventions for children with Developmental Coordination Disorder. Over 9 weeks, participants receive either Obstacle Course Training or Neuromotor Task Training, with two sessions per week, to see which approach better improves motor planning and functional mobility. Outcomes are measured using standardized motor performance assessments. The study is conducted at pediatric rehabilitation centers in Lahore, Pakistan, and aims to guide more effective, task-specific therapies for DCD in school-aged children.

Why it matters

Potential benefit: If successful, the more effective intervention could lead to better daily motor skills and participation in activities for children with DCD.

How similar studies have gone: Prior neuromotor and task-specific training approaches have shown promise in improving motor skills in DCD, though direct head-to-head trials are limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* • Diagnosis of DCD based on DSM4/5 criteria.

  * Children aged 7-10.
  * Gender male and female.
  * Mini-Mental State Examination (MMSE) score \>24 .
  * Cognitive development appropriate for chronological age.
  * Raven Intelligence Test Scale (IQ \> 75) .
  * Developmental Coordination Questionnaire ≤48 points: likely DCD (≤ 10th percentile).
  * BOT-2 score ≤ 40.

Exclusion Criteria:

* History of surgery and lower limb injuries over the past 12 months.
* Use of assistive devices to balance and walk.
* Severe ADHD, Autism Spectrum Disorder (if it significantly interferes with participation), or major psychiatric disorders.
* Taking neuroleptics or any other medications that significantly alter muscle tone, coordination, or attention.

Where it's running

  • University Of Lahore Teaching Hospital ULTH
    Lahore, Punjab Province, Pakistan
    Recruiting
  • Riphah Rehabilitation Center, Riphah International University
    Lahore, Punjab Province, Pakistan
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.